DNA Damage Repair Deficiency
Showing 1 - 25 of >10,000
Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,
Recruiting
- Hormone Sensitive Metastatic Prostate Cancer
- +3 more
- Docetaxel
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022
Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)
Recruiting
- Biliary Tract Cancer
- DNA Damage Repair Deficiency
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 8, 2022
Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)
Recruiting
- Recurrent Glioma
- +4 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology
Aug 19, 2021
Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)
Recruiting
- Lung Cancer
- Olaparib+Bevacizumab to SCLC patients
-
Seoul, Gangnam-gu, Korea, Republic of
- +3 more
Nov 9, 2022
Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)
Recruiting
- Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
-
Clinuvel Investigational Site, United KingdomCLINUVEL Investigational Site
Nov 9, 2022
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)
Not yet recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
- (no location specified)
Jan 14, 2023
Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)
Not yet recruiting
- Advanced Breast Cancer
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 12, 2022
Ultraviolet Rays; Injury, DNA Adduct Formation, DNA Damage, Radiation Induced Trial in Copenhagen NV (Ultraviolet radiation)
Active, not recruiting
- Ultraviolet Rays; Injury
- +3 more
- Ultraviolet radiation
-
Copenhagen NV, DenmarkBispebjerg Hospital, Department of Dermatology
Jul 19, 2022
Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)
Recruiting
- Chronic Lymphocytic Leukemia
- RP-3500 in combination with Olaparib
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 23, 2022
Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)
Completed
- Refractory Cancer
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)
Active, not recruiting
- Castration Resistant Prostatic Cancer
- Metastatic Prostate Cancer
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 17, 2022
ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,
Recruiting
- ATM Gene Mutation
- +16 more
- Niraparib
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
Natural History Study for DNA Repair Disorders
Not yet recruiting
- DNA Repair Disorder
- +3 more
- Interval History
- +4 more
-
Minneapolis, MinnesotaUniversity of Minnesota- Twin Cities
Aug 8, 2022
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,
Recruiting
- MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
- HRO761
- +2 more
-
Kashiwa, Chiba, JapanNovartis Investigative Site
May 2, 2023
BRCA and DNA Damage Repair Genes in Blood Samples of Chinese
Recruiting
- Pancreatic Cancer
- Observation
-
Shanghai, Shanghai, ChinaRenJiH
Nov 17, 2021
Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,
Active, not recruiting
- Endometrial Adenocarcinoma
- +3 more
- Genetic Counseling
- +3 more
-
Akron, Ohio
- +8 more
Dec 2, 2022
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Cancers With DNA Repair-Deficiency Trial in Germany (Olaparib, Physician's choice, Trabectedin)
Recruiting
- Cancers With DNA Repair-Deficiency
- Olaparib
- +2 more
-
Dresden, Germany
- +8 more
Jan 12, 2022
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021
Sleep Quality, DNA Damage Repair Deficiency, Oxidative Stress Trial (Melatonin, Placebo)
Unknown status
- Sleep Quality
- +2 more
- Melatonin
- Placebo
- (no location specified)
May 8, 2019
DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)
Unknown status
- DDR Gene Mutation
- Metastatic Solid Tumor
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles, Ann Arbor,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
-
Los Angeles, California
- +2 more
Aug 3, 2021
Sarcoma,Soft Tissue, Sarcoma Uterus Trial in United States (Niraparib)
Recruiting
- Sarcoma,Soft Tissue
- Sarcoma Uterus
-
Basking Ridge, New Jersey
- +6 more
Aug 23, 2022